This review explores how integrative oncology strategies can support immune checkpoint inhibitor treatment for adult solid tumors. It is important because it can inform decisions on integrating these strategies to enhance the effectiveness of ICI treatment.
Researchers have found that plant-based herbal medicines, specifically [name], have strong anti-tumor properties. This review discusses the progress made in understanding the active constituents and their mechanisms, offering insights for the development of new clinical anticancer drugs.
A strain of Aspergillus terreus in the medicinal plant Catharanthus roseus produces camptothecin (CPT), which exhibits anticancer and wound healing properties. Adding sterilized C. roseus leaves can restore CPT production, making A. terreus a potential source for industrial CPT production.
Coptisine, a compound from Chinese herb, has anti-tumor effect but its impact on rheumatoid arthritis (RA) is unclear. This study investigates coptisine's ability to control synovial proliferation in RA and its mechanism(s).
Scientists developed a chemo-free treatment strategy for triple-negative breast cancer (TNBC) using a nanophytosomal system and phyto-photo dual treatment. Experiment showed promising anti-TNBC activity, suppression of mitochondrial potential, and induction of caspase-3 activity, indicating potential effectiveness and safety of this approach.
This article reviews the processing methods, anti-tumor activities, and clinical applications of Coix seed. It aims to provide information for further research and development of Coix seed as a medicine and food source.
Hosenkoside A from Impatiens balsamina seeds has anti-cervical cancer effects by inhibiting HDAC3, blocking STAT3 activation. Encapsulating it into PMC enhances targeted and sustained-release drug delivery, improving anti-tumor effects.
Bitter melon inhibits breast cancer cell growth, but the exact process is unknown. Understanding the mechanism could lead to potential treatments for BRCA.